Interpretation of Newly Released 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes by American College of Cardiology：Not Only Lowering Glucose，But Also Conferring Cardiovascular Benefits